ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ABL - US0028241000 - Common Stock
107.86 EUR
-1.7 (-1.55%)
Overall ABL gets a fundamental rating of 6 out of 10. We evaluated ABL against 65 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ABL a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, ABL is valued expensive at the moment. This makes ABL very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year ABL was profitable.
In the past year ABL had a positive cash flow from operations.
In the past 5 years ABL has always been profitable.
Each year in the past 5 years ABL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ABL (16.60%) is better than 92.31% of its industry peers.
The Return On Equity of ABL (27.43%) is better than 93.85% of its industry peers.
ABL's Return On Invested Capital of 9.90% is fine compared to the rest of the industry. ABL outperforms 75.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 10.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 9.9% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
ABL has a better Profit Margin (31.88%) than 98.46% of its industry peers.
ABL's Profit Margin has improved in the last couple of years.
ABL's Operating Margin of 18.29% is fine compared to the rest of the industry. ABL outperforms 73.85% of its industry peers.
ABL's Operating Margin has improved in the last couple of years.
ABL has a Gross Margin of 56.19%. This is comparable to the rest of the industry: ABL outperforms 47.69% of its industry peers.
ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABL is creating some value.
Compared to 1 year ago, ABL has about the same amount of shares outstanding.
ABL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
ABL has an Altman-Z score of 5.81. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ABL (5.81) is better than 90.77% of its industry peers.
The Debt to FCF ratio of ABL is 1.87, which is an excellent value as it means it would take ABL, only 1.87 years of fcf income to pay off all of its debts.
ABL has a Debt to FCF ratio of 1.87. This is in the better half of the industry: ABL outperforms 78.46% of its industry peers.
ABL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
ABL has a better Debt to Equity ratio (0.23) than 66.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.81 |
ROIC/WACC1.02
WACC9.72%
2.3 Liquidity
ABL has a Current Ratio of 1.70. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
ABL's Current ratio of 1.70 is in line compared to the rest of the industry. ABL outperforms 53.85% of its industry peers.
ABL has a Quick Ratio of 1.24. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ABL (1.24) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 10.40% over the past year.
ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.59% yearly.
ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.37%.
Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.89% yearly.
The Revenue is expected to grow by 7.22% on average over the next years.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 25.26, ABL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 69.23% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, ABL is valued at the same level.
A Price/Forward Earnings ratio of 21.97 indicates a rather expensive valuation of ABL.
ABL's Price/Forward Earnings is on the same level as the industry average.
ABL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.26 | ||
| Fwd PE | 21.97 |
4.2 Price Multiples
ABL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than the industry average as 63.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.66 | ||
| EV/EBITDA | 20.39 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
ABL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.21
PEG (5Y)3.33
EPS Next 2Y10.8%
EPS Next 3Y10.58%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.00%, ABL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.98, ABL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, ABL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
5.2 History
The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.93% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
FRA:ABL (1/9/2026, 7:00:00 PM)
107.86
-1.7 (-1.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap187.55B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target124.54 (15.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
Yearly Dividend1.9
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-0.82%
PT rev (3m)0.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.26 | ||
| Fwd PE | 21.97 | ||
| P/S | 4.99 | ||
| P/FCF | 31.66 | ||
| P/OCF | 24.01 | ||
| P/B | 4.3 | ||
| P/tB | 10.24 | ||
| EV/EBITDA | 20.39 |
EPS(TTM)4.27
EY3.96%
EPS(NY)4.91
Fwd EY4.55%
FCF(TTM)3.41
FCFY3.16%
OCF(TTM)4.49
OCFY4.16%
SpS21.6
BVpS25.1
TBVpS10.53
PEG (NY)2.21
PEG (5Y)3.33
Graham Number49.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 9.9% | ||
| ROICexc | 11.13% | ||
| ROICexgc | 21.33% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.81 |
F-Score7
WACC9.72%
ROIC/WACC1.02
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Overvalued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 25.26 and the Price/Book (PB) ratio is 4.3.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 28.93%.